Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
International Journal of Oncology
|
May 5, 2011
Progress in anti-invasion and anti-metastasis research and treatment
W Jiang, R Mansel
Psychosomatic Medicine
|
April 16, 1999
Anxiety and adherence to breast self-examination in women with a family history of breast cancer
K Brain, P Norman, J Gray, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 12, 2001
Hepatocyte growth factor modulates vascular endothelial-cadherin expression in human endothelial cells
T A Martin, R Mansel, W G Jiang
British Journal of Cancer
|
July 12, 2007
Cost-effectiveness analysis of anastrozole vs tamoxifen in adjuvant therapy for early stage breast cancer in the United Kingdom: the 5-year completed treatment analysis of the ATAC ('Arimidex', Tamoxifen alone or in combination) trial
R Mansel, G Locker, L Fallowfield, et al.
British Journal of Cancer
|
March 1, 2002
A randomized trial of specialist genetic assessment: psychological impact on women at different levels of familial breast cancer risk
K Brain, P Norman, J Gray, et al.
International Journal of Oncology
|
April 30, 2011
The role of desmoglein 2 and E-cadherin in the invasion and motility of human breast cancer cells
E Davies, R Cochrane, S Hiscox, et al.
Oncology Reports
|
May 20, 2011
Hepatocyte growth factor induces tyrosine phosphorylation of focal adhesion kinase (FAK) and paxillin and enhances cell-matrix interactions
W Jiang, S Hiscox, T Nakamura, et al.
International Journal of Oncology
|
May 5, 2011
Inhibition of membrane ruffling and ezrin translocation by gamma linolenic acid
W Jiang, S Hiscox, M Puntis, et al.
International Journal of Oncology
|
May 6, 2011
Gamma linolenic acid inhibits tyrosine phosphorylation of focal adhesion kinase and paxillin and tumour cell matrix interaction
W Jiang, S Hiscox, M Puntis, et al.
Journal of Medical Genetics
|
March 4, 2000
Why do women attend familial breast cancer clinics?
K Brain, J Gray, P Norman, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
International Journal of Oncology
|
May 5, 2011
Progress in anti-invasion and anti-metastasis research and treatment
W Jiang, R Mansel
Psychosomatic Medicine
|
April 16, 1999
Anxiety and adherence to breast self-examination in women with a family history of breast cancer
K Brain, P Norman, J Gray, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 12, 2001
Hepatocyte growth factor modulates vascular endothelial-cadherin expression in human endothelial cells
T A Martin, R Mansel, W G Jiang
British Journal of Cancer
|
July 12, 2007
Cost-effectiveness analysis of anastrozole vs tamoxifen in adjuvant therapy for early stage breast cancer in the United Kingdom: the 5-year completed treatment analysis of the ATAC ('Arimidex', Tamoxifen alone or in combination) trial
R Mansel, G Locker, L Fallowfield, et al.
British Journal of Cancer
|
March 1, 2002
A randomized trial of specialist genetic assessment: psychological impact on women at different levels of familial breast cancer risk
K Brain, P Norman, J Gray, et al.
International Journal of Oncology
|
April 30, 2011
The role of desmoglein 2 and E-cadherin in the invasion and motility of human breast cancer cells
E Davies, R Cochrane, S Hiscox, et al.
Oncology Reports
|
May 20, 2011
Hepatocyte growth factor induces tyrosine phosphorylation of focal adhesion kinase (FAK) and paxillin and enhances cell-matrix interactions
W Jiang, S Hiscox, T Nakamura, et al.
International Journal of Oncology
|
May 5, 2011
Inhibition of membrane ruffling and ezrin translocation by gamma linolenic acid
W Jiang, S Hiscox, M Puntis, et al.
International Journal of Oncology
|
May 6, 2011
Gamma linolenic acid inhibits tyrosine phosphorylation of focal adhesion kinase and paxillin and tumour cell matrix interaction
W Jiang, S Hiscox, M Puntis, et al.
Journal of Medical Genetics
|
March 4, 2000
Why do women attend familial breast cancer clinics?
K Brain, J Gray, P Norman, et al.
Page
of 2